Atsena Therapeutics

lighthouse in stormy night
Biotech

Gene therapy biotech secures $150M for eye disease candidates

Atsena has raised $150 million to advance its gene therapy designed to reverse or prevent blindness.
Gabrielle Masson Apr 2, 2025 7:30am
close-up image of an eye

Atsena downsizes to funnel money toward new capsid program

Oct 5, 2023 1:47pm
ladder chutes and ladders parachute

Seagen finally finds new CEO—Chutes & Ladders

Nov 11, 2022 9:30am
Dry eye

Eyeing phase 3, Atsena raises $55M financing for gene therapy

Dec 16, 2020 7:30am